| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Other income | -1.7 | 1.0 | 0.5 |
| Total income | 77.2 | 90.5 | 97.3 |
| Net profit | -5.0 | -2.6 | 7.5 |
| Operating margin | -7.6% | -2.8% | 9.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: GEMAROMA. Figures extracted from the filing.
Gem Aromatics Ltd: key numbers
- Share price
- ₹164.91
- Market cap
- ₹861.4 Cr
- Revenue (annual)
- ₹366.5 Cr
- Net profit (annual)
- ₹1.42 Cr
- P/E (TTM)
- -59.7×Sector 36.3×
- Promoter holding
- 57.45%+0.44% QoQ
- FII holding
- 0.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gem Aromatics Ltd
All →Gem Aromatics Acquisition Worth ₹225.2 Cr
Gem Aromatics Limited is acquiring Krystal Ingredients Private Limited for ₹225.21 Crore through the conversion of a loan into equity.
- Value
- ₹225.2 Cr
Gem Aromatics Acquisition
Gem Aromatics Limited approved converting existing inter-company loans into equity shares of its wholly-owned subsidiary, Krystal Ingredients Private Limited, to strengthen the subsidiary's capital base.
- Execution
- Within one month from receipt of requisite approvals
Gem Aromatics Annual Report
The company submitted a revised Annual Report for FY 2025-26, replacing inadvertently attached unfinalized annexures. No content changes were made to the report.
Gem Aromatics Annual General Meeting
Gem Aromatics Limited held its 29th Annual General Meeting on August 19, 2026, via video conferencing. The meeting transacted various business items, including appointment of directors and remuneration.
Gem Aromatics Results Update
Gem Aromatics Ltd reported Q1FY27 financial highlights in a press release. Consolidated revenue reached ₹98.9 Crore, with the company noting seasonally soft performance.
Gem Aromatics Investor Presentation: Key Takeaways
Gem Aromatics reports Q1FY27 standalone revenue growth of 9% YoY. Strategy focuses on scaling the new Dahej facility and expanding into higher-value specialty molecules like cooling agents and phenol derivatives.